Twitxy Saved

Firas F Mussa

@UnTBAD

Surgeon-Trialist, Fact-checker and cynic 🇮🇶🇺🇸🇬🇧 NHLBI-IMPROVE-AD
Houston-NYC-London Joined July 2019
57 Following 756 Followers 2.1K Posts

Latest posts 5

Firas F Mussa @UnTBAD
Thanks @CMichaelGibson for raising awareness. #IMPROVE-AD @VascularSVS
C. Michael Gibson MD Verified account @CMichaelGibson Jul 20
Aortic dissection is a life-threatening emergency where every minute matters. In this interview, Dr. Firas Mussa and I discuss the key signs and symptoms clinicians should recognize, why early diagnosis is so critical, and how the IMPROVE-AD trial aims to advance the care of patients with acute aortic dissection.

For more information on the IMPROVE-AD trial, please email improve-ad@duke.edu

clinicaltrialresults.org/aortic-dissect…
View quoted post on X
Firas F Mussa @UnTBAD
Thanks to @NEJM @NIH For raising awareness and looking for answers when it matters most improvead.org
improvead.org Home - IMPROVE-AD IMPROVE-AD (IMPRoving Outcomes in Vascular DisEase – Aortic Dissection) is a clinical research study. The study aims to understand how best to treat type B aortic dissection. This is a condition...
NEJM Verified account @NEJM Sep 4, 2025
A new review by Firas F. Mussa, MD, and Panos Kougias, MD (@KougiasP), describes the current management of type B aortic dissection, including medical therapy and thoracic endovascular aortic repair.

Learn more in the Review Article “Management of Acute Type B Aortic Dissection” from @McGovernMed and @sunydownstate: nej.md/4mKYgcb
View quoted post on X
Firas F Mussa @UnTBAD
@VascularSVS 🙏 together, we generate the evidence to guide the care of TBAD
Society for Vascular Surgery Verified account @VascularSVS Jun 5
The outcomes of the IMPROVE-AD clinical trial are important to helping identify the best ways to treat type B aortic dissections.

IMPROVE-AD is currently recruiting participating sites to enroll eligible patients. 👉 Learn more: improvead.org #VascSurg
View quoted post on X